| Literature DB >> 23020225 |
Tomoko Komagamine1, Takahide Nagashima, Masaru Kojima, Norito Kokubun, Toshiki Nakamura, Kenich Hashimoto, Kazuhito Kimoto, Koichi Hirata.
Abstract
BACKGROUND: Kikuchi Fujimoto disease (KFD), or histiocytic necrotising lymphadenitis, is a benign and self-limiting condition characterised by primarily affecting the cervical lymph nodes. Recurrent aseptic meningitis in association with KFD is extremely rare and remains a diagnostic challenge. CASEEntities:
Mesh:
Year: 2012 PMID: 23020225 PMCID: PMC3570427 DOI: 10.1186/1471-2377-12-112
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Figure 1Clinical course of the patient. The patient had his first meningitis episode at 21 years of age. Two resolutions and exacerbations occurred within the following 3 months. He had the fourth to seventh episodes of meningitis between 27 and 28 years of age. In each episode the patient’s symptoms and abnormal cerebrospinal fluids were spontaneously resolved. Lymphadenopathy was evident both in the attacks at age 27 and age 28.
Figure 2Histopathological findings of affected lymph node. A: In a low-power field, the affected lymph node showed discreet areas of necrosis paracortex (Hematoxylin-eosin stain, 10X). B: In a high-power field, the lesion demonstrated abundant karyorrhectic debris with apoptosis bodies and numerous histiocytes and large lymphoid cells (arrows). There were no neutrophils in the lesion (Hematoxylin-eosin stain, 100X). C: Giemsa stained section highlighted the plasmacytoid dendritic cells cluster (arrowheads) at the margins of the necrotic foci (may-Giemsa stain, 100X). D: Immunostain demonstrated that many histiocytes in the necrotic area were positive for myeloperoxidase (60X). E: Portions of the hystiocytes were stained with CD68 (60X). The scale bars in each panel indicate 10 μm, except for panel A (50 μm).
The clinical features of recurrent aseptic meningitis cases with Kikuchi-Fujimoto disease
| Age/gender | 21/M | 12/F | 29/M | 35/F | 28/M |
| Meningeal sign | - | + | - | + | + |
| Maximum Cerebrospinal fluid cell count/mm3 | 178 | 100 | 63 | 59 | 137 |
| Duration of the meningitis episode | 10 days | 10 days | 10-30 days | 10 days | 10 – 20 days |
| Interval between each episode | 1 month | 1 week | 11 years | 5 months, 11 months | 1 week to 6 years |
| Coexisting conditions | High titre of anti-Toxoplasma antibody | - | Elevation of serum IgE | High titre of antinuclear antibody | Elevation of serum IgE |
| Steroid Use | - | Oral prednisolone, | Intravenous methyl prednisolone, | Oral prednisolone, | - |
| | | 1 mg/kg | | 40 mg/day | |
| 1000 mg/day |